Previous close | 0.3520 |
Open | 0.3550 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.3350 - 0.3600 |
52-week range | 0.1200 - 0.4800 |
Volume | |
Avg. volume | 144,075 |
Market cap | 38.834M |
Beta (5Y monthly) | 2.26 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that it has commenced discussions with Breathalyser Sales & Service Pty Ltd. of Sydney,
Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement, employers and other organizations tools to enhance public safetyVANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that Friedel, LLC (“Friedel Clinic”) a private monitoring agency, ba
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that it will be presenting at the International Association for Chemical Testing (IACT) conference in April. Cannabix’s Dr